US Patent Issued to The Trustees of the University of Pennsylvania on June 23 for "Interferon pathway genes regulate and predict efficacy of immunotherapy" (Pennsylvania Inventor)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,705, issued on June 23, was assigned to The Trustees of the University of Pennsylvania.

"Interferon pathway genes regulate and predict efficacy of immunotherapy" was invented by Andy J. Minn (Philadelphia).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention includes methods for treating cancer and selecting a patient for immunotherapy administration."

The patent was filed on Sept. 13, 2019, under Application No. 17/274,426.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PT...